Fifth Third Bancorp United Therapeutics Corp Transaction History

Fifth Third Bancorp

  • $27.1 Billion
  • Q4 2024

A detailed history of Fifth Third Bancorp transactions in United Therapeutics Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 397 shares of UTHR stock, worth $139,414. This represents 0.0% of its overall portfolio holdings.

Number of Shares
397
Previous 435 8.74%
Holding current value
$139,414
Previous $155,000 9.68%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$348.66 - $410.0 $13,249 - $15,580
-38 Reduced 8.74%
397 $140,000
Q3 2024

Oct 17, 2024
SELL
$311.04 - $363.55 $46,656 - $54,532
-150 Reduced 25.64%
435 $155,000
Q2 2024

Jul 22, 2024
BUY
$228.26 - $319.04 $15,521 - $21,694
68 Added 13.15%
585 $186,000
Q1 2024

Apr 23, 2024
SELL
$210.76 - $249.51 $237,315 - $280,948
-1,126 Reduced 68.53%
517 $118,000
Q4 2023

Jan 19, 2024
SELL
$214.88 - $256.94 $34,380 - $41,110
-160 Reduced 8.87%
1,643 $361,000
Q3 2023

Oct 31, 2023
BUY
$211.82 - $248.24 $37,068 - $43,442
175 Added 10.75%
1,803 $407,000
Q2 2023

Jul 25, 2023
SELL
$205.19 - $232.99 $9,849 - $11,183
-48 Reduced 2.86%
1,628 $359,000
Q1 2023

Apr 24, 2023
SELL
$212.99 - $276.17 $117,783 - $152,722
-553 Reduced 24.81%
1,676 $375,000
Q4 2022

Jan 25, 2023
SELL
$205.95 - $280.43 $55,606 - $75,716
-270 Reduced 10.8%
2,229 $0
Q3 2022

Oct 25, 2022
BUY
$203.3 - $244.17 $14,840 - $17,824
73 Added 3.01%
2,499 $523,000
Q2 2022

Aug 04, 2022
BUY
$174.81 - $241.14 $9,264 - $12,780
53 Added 2.23%
2,426 $572,000
Q1 2022

Apr 19, 2022
BUY
$166.16 - $213.96 $28,911 - $37,229
174 Added 7.91%
2,373 $426,000
Q4 2021

Feb 01, 2022
BUY
$184.32 - $216.08 $35,758 - $41,919
194 Added 9.68%
2,199 $475,000
Q3 2021

Oct 15, 2021
BUY
$179.86 - $214.88 $334,719 - $399,891
1,861 Added 1292.36%
2,005 $370,000
Q1 2021

May 07, 2021
BUY
$153.94 - $174.85 $6,927 - $7,868
45 Added 45.45%
144 $24,000
Q4 2020

Feb 16, 2021
BUY
$101.87 - $151.79 $8,149 - $12,143
80 Added 421.05%
99 $15,000
Q3 2020

Nov 09, 2020
BUY
$99.9 - $121.13 $1,898 - $2,301
19 New
19 $2,000
Q3 2019

Nov 14, 2019
SELL
$74.85 - $85.99 $2,095 - $2,407
-28 Closed
0 $0
Q2 2019

Aug 07, 2019
BUY
$76.06 - $120.81 $2,129 - $3,382
28 New
28 $2,000
Q1 2019

May 14, 2019
SELL
$107.15 - $126.84 $214 - $253
-2 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$101.4 - $128.73 $202 - $257
2 New
2 $0

Others Institutions Holding UTHR

# of Institutions
681
Shares Held
42.2M
Call Options Held
194K
Put Options Held
298K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email